Glaxo in potential $1.9 billion tax battle with IRS | Reuters

[Guest guest]

http://www.reuters.com/article/businessNews/idUSTRE54L1P520090522?feedType=RSS & f\

eedName=businessNews & sp=true

Glaxo, the world's second-largest drugmaker

" NEW YORK/LONDON (Reuters) - British-based drug company

GlaxoKline is battling the U.S. Internal Revenue Service over a

potential $1.9 billion in back taxes, interest and penalties "

Here are Glaxo's vaccines also have the new h1n1 vaccine):

<http://www.boostrix.com/hcp/index.html>

BOOSTRIX

<https://www.gskvaccinesdirect.com/gsk/en/US/htdocs/products/INFANRIX/index.htm>

Infanrix

<https://www.gskvaccinesdirect.com/gsk/en/US/htdocs/products/ENGERIX/index.htm>

Engerix_B

<http://www.kinrix.com/hcp/>

Kinrix

<https://www.gskvaccinesdirect.com/gsk/en/US/htdocs/products/FLUARIX/index.htm>

Fluarix

<http://www.pediarix.com>

Pediarix

<https://www.gskvaccinesdirect.com/gsk/en/US/htdocs/products/FLULAVAL/index.htm>

FluLaval

<http://www.rotarix.com/>

Rotarix

<http://www.havrix.com/>

Havrix

<http://www.twinrix.com/>

TWINRIX

Sheri Nakken, R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Washington State, USA

Vaccines - http://www.nccn.net/~wwithin/vaccine.htm or

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers, Childhood Disease Classes & Homeopathy Online/email

courses - next classes start May 20 & 21

http://www.wellwithin1.com/vaccineclass.htm or

http://www.wellwithin1.com/homeo.htm